A story from the U.K.’s “Manchester Evening News” tells the story of a 57-year-old mother of two who spent months unable to work or leave her house because of a DePuy all-metal artificial hip implant.
Sally Gration, 57, underwent hip replacement surgery in February 2006 to treat hip dysplasia, or a malformed hip joint.
Initially, the surgery appeared to be successful. But she began suffering excruciating pain in 2010 – the year ...
continue reading...
According to a story in the New York Times, a renewed U.S. Justice Department emphasis on prosecuting corporate fraud is expected to bring in as much as $8 billion this year from pharmaceutical companies, military contractors, banks and other corporations charged with defrauding the government, which amounts to a record sum.
Still, the lack of charges against executives at those companies is resurrecting questions about accountability, and just how much of ...
continue reading...
A prominent Wall Street analyst is suggesting that the best way for Johnson & Johnson to cope with its many problems would be to break into smaller companies, according to an article in the Asbury Park Press.
Jami Rubin of Goldman Sachs suggests that splitting Johnson & Johnson’s three divisions into separate companies would free up money to invest, help the company grow faster and provide a bigger return to shareholders.
The ...
continue reading...
Johnson & Johnson’s Synthes unit, a maker of tools and implants to treat damaged bones, has been sued by the family of a woman who died during an unapproved trial of a bone cement, Bloomberg reports.
It’s an ironic development for Johnson & Johnson, which recently purchased Synthes for $19.7 billion, largely in the hopes it would help offset revenue losses related to a series of recalls and legal problems over ...
continue reading...
A state appeals court has upheld the dismissal of Pennsylvania’s lawsuit against Johnson & Johnson over allegations that the company improperly marketed its antipsychotic drug Risperdal, the Wall Street Journal reports.
Pennsylvania prosecutors had filed suit against J&J in 2007, trying to recover expenses incurred by the state’s Medicaid program for reimbursing pharmacies over the purchase of Risperdal. Prosecutors alleged that J&J had promoted Risperdal for unapproved – or “off-label” – ...
continue reading...
Christine Scott, a woman awarded $5.5 million for injuries from a transvaginal mesh implant, said she hopes the development will help “get the word out to women,” according to a report on KGET out of California.
A California jury ruled this week that C.R. Bard Medical, maker of Avaulta Mesh, is responsible for the damages. It’s the first case involving vaginal mesh implants to go to trial, but over 600 more ...
continue reading...
